XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating Expenses:        
Research and development $ 11,392 $ 11,669 $ 33,522 $ 25,596
General and administrative 3,071 3,076 9,721 9,939
Total operating expenses 14,463 14,745 43,243 35,535
Loss from operations (14,463) (14,745) (43,243) (35,535)
Other income (expense):        
Grant income 4,293 7,684 16,516 18,035
Other income (expense), net 236 314 813 (129)
Interest expense (3) (2) (20) (18)
Loss on currency translation from liquidation of subsidiary     (195)  
Total other income, net 4,526 7,996 17,114 17,888
Net loss (9,937) (6,749) (26,129) (17,647)
Foreign currency translation adjustment, including reclassifications     195 3
Total comprehensive loss $ (9,937) $ (6,749) $ (25,934) $ (17,644)
Net loss per share, basic (in dollars per share) $ (0.25) $ (0.22) $ (0.69) $ (0.59)
Net loss per share, diluted (in dollars per share) $ (0.25) $ (0.22) $ (0.69) $ (0.59)
Weighted-average common shares outstanding, basic (in shares) 40,418,065 30,365,506 38,080,658 29,696,296
Weighted-average common shares outstanding, diluted (in shares) 40,418,065 30,365,506 38,080,658 29,696,296